Ultrasound-activated nanomaterials for sonodynamic cancer theranostics

Nan Wu1, Ching-Hsiang Fan2, Chih-Kuang Yeh1

  • 1Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu, Taiwan.

Drug Discovery Today
|March 5, 2022
PubMed

Insights

Sonodynamic therapy (SDT) uses ultrasound and sonosensitizers to treat cancer, offering a promising approach to overcome challenges like drug resistance and recurrence. This review explores SDT mechanisms, efficacy, and future potential in oncology.

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Nanomedicine

Background:

  • Cancer treatment faces challenges including unclear tumor margins, recurrence, and chemotherapy resistance.
  • Sonodynamic therapy (SDT) is an emerging modality utilizing ultrasound and sonosensitizers for cancer treatment.

Purpose of the Study:

  • To review the current understanding of sonodynamic therapy mechanisms.
  • To evaluate the preclinical and clinical efficacy of SDT in tumor treatment.
  • To discuss the limitations and future directions of SDT in oncology.

Main Methods:

  • Review of existing literature on sonodynamic therapy.
  • Analysis of preclinical studies and clinical trials involving SDT applications in tumors.
  • Discussion of the underlying mechanisms of SDT.

Main Results:

  • SDT demonstrates potential as a promising cancer therapy approach.
  • Evidence of preclinical and clinical efficacy in various tumor models.
  • Identification of key mechanisms driving SDT's therapeutic effects.

Conclusions:

  • Sonodynamic therapy holds significant therapeutic potential for cancer treatment.
  • Further research is needed to address limitations and optimize SDT applications.
  • SDT represents a promising future direction in oncological therapy.